Oncternal Therapeutics Inc. Stock
With 21 Sell predictions and only 3 Buy predictions Oncternal Therapeutics Inc. is one of the least favorite stocks of our community.
On the other hand, the target price of 1 € is above the current price of 0.32 € for Oncternal Therapeutics Inc., so the potential is actually 216.46%.
Our community identified positive and negative aspects for Oncternal Therapeutics Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Oncternal Therapeutics Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
Pros and Cons of Oncternal Therapeutics Inc. in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its price target raised by analysts at HC Wainwright to $30.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ONCT provided by MarketBeat